Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer Genomics and Proteomics is Scopus-indexed (Q2, CiteScore 4.9), WoS SCIE. Published by International Institute of Anticancer Research.
Checked against the index lists dated .
ISSN 1109-6535Verify ISSN ↗1790-6245Verify ISSN ↗
Publisher: International Institute of Anticancer Research
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics | 164 / 357 | 54th | Q2 |
| Biochemistry | 226 / 448 | 49th | Q3 |
| Cancer Research | 131 / 233 | 43rd | Q3 |
| Molecular Biology | 233 / 414 | 43rd | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2004–present, best quartile Q2, CiteScore 4.9.
Cancer Genomics and Proteomics is Q2 in Genetics (rank 164 of 357), Q3 in Biochemistry (rank 226 of 448) and Q3 in Cancer Research (rank 131 of 233), by CiteScore 2025. It is ranked in 4 subject areas in all.
Cancer Genomics and Proteomics is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.9, which places it in quartile Q2 at the 54th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.807, quartile Q2, with an H-index of 53.
Cancer Genomics and Proteomics is published by International Institute of Anticancer Research. Its print ISSN is 1109-6535 and its online ISSN is 1790-6245.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Cancer Genomics and Proteomics has an h-index of 38 and a 2-year mean of 1.96 citations per paper (OpenAlex). Its Scopus CiteScore is 4.9, quartile Q2. On 2-year citations it ranks #216 of 353 Scopus journals in Genetics.
Cancer Genomics and Proteomics published 63 papers in 2025; its busiest recent year was 2021 with 71. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from Taiwan (19.6%), United States (17.8%) and Japan (15.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.